Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
11 avr. 2023 08h30 HE
|
Veru Inc.
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru further expands study of sabizabulin for the treatment of poxvirus acute respiratory distress...